首页>
外国专利>
TREATMENT OF PATIENTS OBTAINING BONE MARROW TRANSPLANTATION OR TRANSPLANTATION OF PERIPHERAL BLOOD TEMM CELLS WITH ANTI-CD20 ANTIBODIES
TREATMENT OF PATIENTS OBTAINING BONE MARROW TRANSPLANTATION OR TRANSPLANTATION OF PERIPHERAL BLOOD TEMM CELLS WITH ANTI-CD20 ANTIBODIES
展开▼
机译:抗CD20抗体治疗骨骨髓移植或外周血骨髓细胞移植的患者
展开▼
页面导航
摘要
著录项
相似文献
摘要
The use of anti-CD20 antibodies as in vivo purging agents for patients receiving bone marrow or peripheral blood stem cell transplant during treatment of B-cell-related diseases, e.g., B-cell lymphomas or leukemias, is disclosed. Such purging may enhance engraftment and/or prevent disease relapse in such patients.
展开▼